Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_2
4
67%
Ph early_phase_1
1
17%

Phase Distribution

1

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
4(66.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (16.7%)
Phase 24 (66.7%)
N/A1 (16.7%)

Trials by Status

recruiting117%
unknown117%
withdrawn117%
completed233%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_2

Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression

NCT06751784
withdrawnphase_2

Influence of Fampridine on Working Memory in Healthy Subjects

NCT04516603
terminatednot_applicable

Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment

NCT05274477
completedphase_2

Influence of Fampridine on Working Memory in Healthy Young Subjects

NCT04652557
unknownearly_phase_1

Fampridine-SR and Optic Neuritis Recovery

NCT04148781
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06751784Phase 2

Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression

Recruiting
NCT04516603Phase 2

Influence of Fampridine on Working Memory in Healthy Subjects

Withdrawn
NCT05274477Not Applicable

Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment

Terminated
NCT04652557Phase 2

Influence of Fampridine on Working Memory in Healthy Young Subjects

Completed
NCT04148781Early Phase 1

Fampridine-SR and Optic Neuritis Recovery

Unknown
NCT01667497Phase 2

Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6